Search results
How a Florida man overcame a broken femur, fractured pelvis and now heart disease
Tampa Bay Times· 14 hours agoLast month, 50 years of bike riding, running and pretending I’m Arnold Schwarzenegger in the gym failed me. With three grandparents dying of heart disease, I knew all along I was doomed. Late ...
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
The Sun Chronicle· 3 days agoNEW YORK, April 29, 2024 /PRNewswire/ --
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 23 hours agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 7 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 5 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
Johnson & Johnson (NYSE:JNJ) Shares Acquired by Callan Capital LLC
ETF DAILY NEWS· 1 day agoCallan Capital LLC lifted its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 4 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Argonautica Private Wealth Management Inc. Boosts Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoArgonautica Private Wealth Management Inc. increased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent ...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 1 day agoAbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports. Barclays‘s ...
Keeler Thomas Management LLC Lowers Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoKeeler Thomas Management LLC trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 15.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC ...